Literature DB >> 18852499

The use of propensity score methods in psychotherapy research. A practical application.

Anna Bartak1, Marieke D Spreeuwenberg, Helene Andrea, Jan J V Busschbach, Marcel A Croon, Roel Verheul, Paul M G Emmelkamp, Theo Stijnen.   

Abstract

BACKGROUND: Randomized controlled trials are considered the best scientific proof of effectiveness. There is increasing concern, though, about their feasibility in psychotherapy research. We discuss a quasi-experimental study design for situations in which a randomized controlled trial is not feasible. Here, as an alternative strategy, the propensity score (PS) method is used to correct for selection bias.
METHODS: We used data from a Dutch research project, SCEPTRE (Study on Cost-Effectiveness of Personality Disorder Treatment). The sample consisted of 749 psychotherapy patients with personality pathology. We tested whether the PS method was useful and applicable. We examined differences between 2 treatment groups (short vs. long treatment duration) in pretreatment characteristics before and after PS correction. This revealed the impact of the PS on outcome differences.
RESULTS: The PS offered statistical control over observed pretreatment differences between patients in a non-randomized study.
CONCLUSIONS: When a randomized controlled trial is not possible, this quasi-experimental design using the PS could be a feasible alternative. Its advantages and limitations are discussed. Implemented carefully, this method is promising for future effectiveness research. 2008 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2008        PMID: 18852499     DOI: 10.1159/000162298

Source DB:  PubMed          Journal:  Psychother Psychosom        ISSN: 0033-3190            Impact factor:   17.659


  8 in total

1.  Heterogeneity in responses to a universal prevention program.

Authors:  Rolf Sandell; Birgitta Kimber
Journal:  J Prim Prev       Date:  2013-12

2.  Puzzling findings in studying the outcome of "real world" adolescent mental health services: the TRAILS study.

Authors:  Frederike Jörg; Johan Ormel; Sijmen A Reijneveld; Daniëlle E M C Jansen; Frank C Verhulst; Albertine J Oldehinkel
Journal:  PLoS One       Date:  2012-09-19       Impact factor: 3.240

3.  An Investigation of Diagnostic Accuracy and Confidence Associated with Diagnostic Checklists as Well as Gender Biases in Relation to Mental Disorders.

Authors:  Jan C Cwik; Fabienne Papen; Jan-Erik Lemke; Jürgen Margraf
Journal:  Front Psychol       Date:  2016-11-22

4.  Evaluating a Dutch cardiology primary care plus intervention on the Triple Aim outcomes: study design of a practice-based quantitative and qualitative research.

Authors:  Tessa C C Quanjel; Marieke D Spreeuwenberg; Jeroen N Struijs; Caroline A Baan; Dirk Ruwaard
Journal:  BMC Health Serv Res       Date:  2017-09-06       Impact factor: 2.655

5.  Severe Mental Health Symptoms during COVID-19: A Comparison of the United Kingdom and Austria.

Authors:  Sanja Budimir; Christoph Pieh; Rachel Dale; Thomas Probst
Journal:  Healthcare (Basel)       Date:  2021-02-09

6.  Patients' perspectives on a new delivery model in primary care: A propensity score matched analysis of patient-reported outcomes in a Dutch cohort study.

Authors:  Esther H A van den Bogaart; Marieke D Spreeuwenberg; Mariëlle E A L Kroese; Sofie J M van Hoof; Niels Hameleers; Dirk Ruwaard
Journal:  J Eval Clin Pract       Date:  2020-06-17       Impact factor: 2.431

7.  Health Behaviors in Austrian Apprentices and School Students during the COVID-19 Pandemic.

Authors:  Teresa O'Rourke; Rachel Dale; Elke Humer; Thomas Probst; Paul Plener; Christoph Pieh
Journal:  Int J Environ Res Public Health       Date:  2022-01-18       Impact factor: 3.390

8.  Mental health burden of high school students, and suggestions for psychosocial support, 1.5 years into the COVID-19 pandemic in Austria.

Authors:  Rachel Dale; Andrea Jesser; Christoph Pieh; Teresa O'Rourke; Thomas Probst; Elke Humer
Journal:  Eur Child Adolesc Psychiatry       Date:  2022-07-28       Impact factor: 5.349

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.